BIIB
50
-2
AVY
44
-3
WFC
66
-3
CPB
32
-8
HCA
66
2
GPC
53
-4
KIM
60
2
PCG
61
-5
UNM
52
2
HPQ
46
2
DG
72
4
PNW
60
8
VIX
49
3
NDAQ
69
2
MLM
60
-6
BLK
60
2
LYB
13
2
DUK
47
-3
ALL
47
-3
MAR
48
-5
BIIB
50
-2
AVY
44
-3
WFC
66
-3
CPB
32
-8
HCA
66
2
GPC
53
-4
KIM
60
2
PCG
61
-5
UNM
52
2
HPQ
46
2
DG
72
4
PNW
60
8
VIX
49
3
NDAQ
69
2
MLM
60
-6
BLK
60
2
LYB
13
2
DUK
47
-3
ALL
47
-3
MAR
48
-5
Financhill
Back

Abits Group, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
37

ABTS
Abits Group, Inc.

Last Price:
$6.41
Seasonality Move:
-4.69%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Sell
37
Abits Group, Inc. (ABTS) is a Sell

Is Abits Group, Inc. a Buy, Sell or Hold?

  • The current Abits Group, Inc. [ABTS] share price is $6.49. The Score for ABTS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ABTS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

ABTS Stock Price Chart

What is Abits Group, Inc.'s stock price today?

  • The Abits Group, Inc. share price today is $6.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABTS is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

ABTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 52.81 Buy
Chaikin Money Flow: 15267 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.73 - 6.33) Buy
Bollinger Bands (100): (4 - 7.72) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

ABTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.07 Buy
20-day SMA: 6.01 Buy
50-day SMA: 7.02 Sell
200-day SMA: 4.8 Buy
8-day EMA: 6.09 Buy
20-day EMA: 6.13 Buy
50-day EMA: 6.3 Buy
200-day EMA: 5.91 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Abits Group, Inc. Earnings Growth & ABTS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Abits Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):